FiberCel Bone Repair Product Recalled Due to Tuberculosis Infections
Aziyo Biologics issued a recall of its FiberCel Fiber Viable Bone Matrix product after several patients tested positive for tuberculosis after treatment. FiberCel is a product made from human tissue that is used in orthopedic procedures to promote bone growth. The company confirmed the contaminated product was shipped to healthcare facilities in 20 states. Tuberculosis is a bacterial respiratory infection that is easily spread through microscopic droplets released into the air when a person coughs, sneezes, or speaks. Tuberculosis mainly affects the lungs although more serious infections can also affect the kidneys, spine or brain.
If you had an orthopedic or spinal procedure that involved the use of FiberCel Fiber Viable Bone Matrix, and have been diagnosed with tuberculosis, contact us. Our product liability attorneys can provide you with a free, no obligation consultation and advise you of your legal rights. Our attorneys have helped thousands of people who have been injured by defective drugs and medical devices get compensation for their injuries. Learn more about our practice and how we can help you here.
